glutamic acid has been researched along with ACY2 Deficiency in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 10 (90.91) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Attwell, D; Hamilton, NB; Káradóttir, R; Kolodziejczyk, K; Wade, A | 1 |
Campbell, GA; Ezell, EL; Matalon, R; Michals-Matalon, K; Quast, MJ; Rady, PL; Rassin, DK; Surendran, S; Szucs, S; Tyring, SK; Wei, J | 1 |
Matalon, KM; Matalon, R; Surendran, S; Szucs, S; Tyring, SK | 1 |
Matalon, R; Michals-Matalon, K; Surendran, S; Tyring, SK | 1 |
Bhattacharya, P; Harris, K; Lin, A; Ross, B; Tran, T; Wong, W | 1 |
de Vellis, J; Kumar, S; Mattan, NS | 1 |
Berrin, JG; Giardina, T; Herga, S; Perrier, J; Puigserver, A | 1 |
Auberson, M; Blanz, J; Hübner, CA; Jentsch, TJ; Maier, H; Muenscher, A; Schweizer, M | 1 |
Blüml, S | 1 |
Blüml, S; Hwang, JH; Moreno, A; Ross, BD | 1 |
Blüml, S; Moreno, A; Ross, BD | 1 |
2 review(s) available for glutamic acid and ACY2 Deficiency
Article | Year |
---|---|
Canavan disease: studies on the knockout mouse.
Topics: Amidohydrolases; Animals; Canavan Disease; Dipeptides; gamma-Aminobutyric Acid; Gene Targeting; Genetic Therapy; Glutamic Acid; Humans; Mice; Mice, Knockout; Phenotype; Stem Cell Transplantation | 2006 |
Canavan disease: a white matter disorder.
Topics: Aspartic Acid; Biomarkers; Brain; Canavan Disease; Diagnosis, Differential; Genetic Counseling; Glutamic Acid; Homeostasis; Humans; Infant; Magnetic Resonance Imaging; Myelin Sheath; Neuroglia; Neurons; Oligodendroglia | 2006 |
1 trial(s) available for glutamic acid and ACY2 Deficiency
Article | Year |
---|---|
Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion.
Topics: Adult; Amidohydrolases; Aspartic Acid; Brain; Canavan Disease; Carbon Isotopes; Child, Preschool; Glucose; Glutamic Acid; Humans; Infusions, Intravenous; Intubation, Gastrointestinal; Magnetic Resonance Spectroscopy; Predictive Value of Tests | 2001 |
8 other study(ies) available for glutamic acid and ACY2 Deficiency
Article | Year |
---|---|
The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes.
Topics: Action Potentials; Animals; Aspartic Acid; Calcium; Canavan Disease; Cerebellum; Dipeptides; Evoked Potentials; Glutamic Acid; Hydrolysis; Oligodendroglia; Patch-Clamp Techniques; Pelizaeus-Merzbacher Disease; Rats; Receptors, N-Methyl-D-Aspartate; Tissue Culture Techniques | 2009 |
Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease.
Topics: Amino Acid Transport System X-AG; Analysis of Variance; Animals; Azo Compounds; Brain Chemistry; Canavan Disease; Creatine; Dipeptides; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; In Vitro Techniques; Insect Proteins; Magnetic Resonance Spectroscopy; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Receptors, GABA-A; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, Protein | 2003 |
Metabolic changes in the knockout mouse for Canavan's disease: implications for patients with Canavan's disease.
Topics: Animals; Aspartate Aminotransferases; Aspartic Acid; Body Weight; Canavan Disease; Disease Models, Animal; Glutamic Acid; Humans; Mice; Mice, Knockout | 2003 |
Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia.
Topics: Alzheimer Disease; Aspartic Acid; Brain; Canavan Disease; Child; Glutamic Acid; Humans; Magnetic Resonance Imaging; Molecular Structure; Schizophrenia | 2006 |
Identification of the zinc binding ligands and the catalytic residue in human aspartoacylase, an enzyme involved in Canavan disease.
Topics: Amidohydrolases; Amino Acid Sequence; Amino Acid Substitution; Base Sequence; Canavan Disease; Catalytic Domain; DNA, Complementary; Escherichia coli; Glutamic Acid; Histidine; Humans; In Vitro Techniques; Kinetics; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Weight; Mutagenesis, Site-Directed; Recombinant Proteins; Sequence Homology, Amino Acid; Zinc | 2006 |
Leukoencephalopathy upon disruption of the chloride channel ClC-2.
Topics: Age Factors; Animals; Axons; Blood-Brain Barrier; Brain; Brain Diseases; Canavan Disease; Chloride Channels; CLC-2 Chloride Channels; Demyelinating Diseases; Epilepsy; Glutamic Acid; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Mutation; Myelin Sheath; RNA, Complementary; Subcellular Fractions; Time Factors; Up-Regulation; Vacuoles | 2007 |
In vivo quantitation of cerebral metabolite concentrations using natural abundance 13C MRS at 1.5 T.
Topics: Aspartic Acid; Brain; Canavan Disease; Carbon Isotopes; Child; Child, Preschool; Glutamic Acid; Glutamine; Humans; Hydrogen Bonding; Infant; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Sensitivity and Specificity; Spin Labels; Synaptic Transmission | 1999 |
1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Diseases; Canavan Disease; Carbon Isotopes; Child; Child, Preschool; Female; Glucose; Glutamic Acid; Hepatic Encephalopathy; Humans; Infant, Newborn; Infant, Premature; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2001 |